维普期刊资源整合服务平台（V6.5）

75篇 您的检索式：作者名="Harris LN"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Preoperative therapy with trastuzumab and paclitaxel followed by sequential adjuvant doxorubicin/cyclophosphamide for HER2 overexpressing stage Ⅱ or Ⅲ breast cancer a pilot study显示文摘	Burstein HJ Harris LN Gelman R	2003	J Clin Oncol2003，21，：	1
2	The HER2 extracellular domain as a prognostic and predictive factor in breast cancer 显示文摘	Nunes RA Harris LN	2002	Clin Breast Cancer2002，3，2：	1
3	Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease, results from CALGB 9342显示文摘	Harris LN Breadwater G Lin NU	2006	Breast Cancer Res2006，8，6：	1
4	Trastuzumab-induced HER reprogramming in 'resistant” breast carcinoma cells显示文摘	Naravan M Wilken JA Harris LN		0，，06：	1
5	Predictors of resistance to preoperative trastuzumab and vinorelbine for HER-2-positive early breast cancer显示文摘	Harris LN You F Schnitt SJ	2007	Clin Cancer Res2007，13，4：	1
6	Preoperative therapy with transtuzumab and paclitaxel followed by sequential adjuvant doxorubicin/cyclophosphanide for HER2 overexpressing stage Ⅱ or Ⅲ breast cancer a pilot study显示文摘	Burestein H J Harris LN Gehnan R	2003	J Clin Oncol2003，21，1：	1
7	Triple negative breast cancer: current understanding of biology and treatment options显示文摘	Kang SP Martel M Harris LN	2008	Curr Opin Obstet Gynecol2008，20，1：	1
8	Novel antifilamin-A antibody detects a secreted variant of filamin-A in plasma from patients with breast carcinoma and highgrade as trocytoma显示文摘	AlperO Stetler-Stevenson WG Harris LN	2009	Cancer Sci2009，100，9：	1
9	Induction of topoisomerase II activity after ErbB2 activation is associated with a differential response to breast cancer chemotherapy 显示文摘	Harris LN Yang L Liotcheva V	2001	Clin Cancer Res2001，7，6：	1
10	Trastuzumab and Vinorelbine as first-line therapy for Her2-overexpressing metastatic breast cancer:muhicenter phase Ⅱ trial with clinical outcomes,analysis of serum tumor markers as predictive factors,and cardiac surveillance algorithm显示文摘	Burstein HJ Harris LN Mareom PK	2003	J Clin Oncol2003，21，：	1
11	The HER2 extracellular domain as a prognostic and predictive factor in breast cancer显示文摘	Nunes RA Harris LN	2002	Clin Breast Cancer2002，3，2：	1
12	Harvest health: translation of the chronic disease self-manage-merit program for older Afi-ican Americans in a senior setting 显示文摘	Gitlin LN Chemett NL Harris LF	2008	Gerontologist2008，48，5：	1
13	Early clinical experiences from students' perspectives: A qualitative study of narratives 显示文摘	Dyrbye LN Harris 1 Rohren CH	2007	Acad Med2007，82，10：	1
14	Triple negative breast cancer: current understanding of biology and treatment options 显示文摘	Kang SP Mar'tel M Harris LN	2008	Curr Opin Obstet Gynecol2008，20，1：	1
15	Trastuzumab-induced HER reprogramming in ' resistant' breast-carcinoma cells 显示文摘	Narayan M Wilken JA Harris LN	2009	Cancer Res2009，69，6：	1
16	Triple negative breast cancer:current under-standing of bilolgy and treatment options显示文摘	Kang SP Martel M Harris LN	2008	Curr Opin Obstet Gynecol2008，20，1：	1
17	Tol<:rability of andadherence to combination oral therapy with gefitinib andcapecitabine in mrtastatic breast cancer 显示文摘	Mayer EL Partridge AH Harris LN	2009	Breast Cancer ResTreat2009，117，3：	1
18	Trastuzumab and vinorelbine as first-line therapy for HER2-overex- pressing metastatic breast cancer: multicenter phase II trial with clinical outcomes, analysis of serum tumor markers as predictive factors, and cardiac surveillance algorithm显示文摘	Burstein H J Harris LN Marcom PK	2003	J Clin Oncol2003，21，15：	1
19	Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in woman with metastatic disease:results from CALGB 9342显示文摘	Harris LN Broadwater G Lin NU	2006	Breast Cancer Res2006，8，6：	1
20	Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: muhicenter phase 11 trial with clinical outcomes, analysis of serum tumor markers as predictive factors, and cardiac surveillance algorithm显示文摘	Burstein HJ Harris LN Marcom PK	2003	J Clin Oncol2003，21，15：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示